Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Patients with Advanced Renal Cell Carcinoma
.
Show all posts
Showing posts with label
Patients with Advanced Renal Cell Carcinoma
.
Show all posts
Monday, September 12, 2016
Exelixis Announces FDA Approval of Cabometyx (cabozantinib) for Patients with Advanced Renal Cell Carcinoma
›
In continuation of my update on cabozantinib Exelixis, Inc. announced that the U.S. Food and Drug Administration (FDA) h...
›
Home
View web version
